{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:36:38Z","timestamp":1777462598062,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI089859"],"award-info":[{"award-number":["U01AI089859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.06.031","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T07:15:38Z","timestamp":1434438938000},"page":"3682-3688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults"],"prefix":"10.1016","volume":"33","author":[{"given":"Richard B.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritish K.","family":"Tosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista M.","family":"Goergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann L.","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Sep (RR-07)","key":"10.1016\/j.vaccine.2015.06.031_bib0190","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2013\u20132014","volume":"62","author":"Advisory Committee on Immunization Practices","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2015.06.031_bib0195","doi-asserted-by":"crossref","first-page":"e76318","DOI":"10.1371\/journal.pone.0076318","article-title":"Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged\u226565 years: estimates with generalized linear models accounting for healthy vaccinee effects","volume":"8","author":"Ridenhour","year":"2013","journal-title":"PLoS ONE"},{"issue":"Aug (4)","key":"10.1016\/j.vaccine.2015.06.031_bib0200","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.coi.2013.07.009","article-title":"Variability in the immune system: of vaccine responses and immune states","volume":"25","author":"Shen-Orr","year":"2013","journal-title":"Curr Opin Immunol"},{"issue":"Dec (4)","key":"10.1016\/j.vaccine.2015.06.031_bib0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"Oct (8)","key":"10.1016\/j.vaccine.2015.06.031_bib0210","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/jit372","article-title":"Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children","volume":"208","author":"Ng","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0215","series-title":"Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines","author":"FDA","year":"2007"},{"issue":"5","key":"10.1016\/j.vaccine.2015.06.031_bib0220","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunological assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0225","series-title":"The compelling need for game-changing influenza vaccines: an analysis of the influenza vaccine enterprise and recommendations for the future","author":"Osterholm","year":"2012"},{"issue":"Mar (2)","key":"10.1016\/j.vaccine.2015.06.031_bib0230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/vim.2013.0099","article-title":"Detection of influenza A\/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay","volume":"27","author":"Painter","year":"2014","journal-title":"Viral Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.031_bib0235","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.031_bib0240","doi-asserted-by":"crossref","first-page":"e0122282","DOI":"10.1371\/journal.pone.0122282","article-title":"The impact of immunosenescence on humoral immune response variation after influenza A\/H1N1 vaccination in older subjects","volume":"10","author":"Haralambieva","year":"2015","journal-title":"PLoS ONE"},{"issue":"Dec","key":"10.1016\/j.vaccine.2015.06.031_bib0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2013.09.007","article-title":"ELISPOT assay to measure influenza-specific cellular immunity","volume":"398\u2013399","author":"Salk","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0250","series-title":"WHO global influenza surveillance network: manual for the laboratory diagnosis and virological surveillance of influenza","author":"WH Organisation","year":"2011"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0255","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.031_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0265","series-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of forecasts expressed in terms of probability","volume":"78","author":"Brier","year":"1950","journal-title":"Mon Weather Rev"},{"key":"10.1016\/j.vaccine.2015.06.031_bib0275","series-title":"Statistics for Biology and Health","article-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2009"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.031_bib0280","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/21645515.2015.1011990","article-title":"Profiles of influenza A\/H1N1 vaccine response using hemagglutination-inhibition titers","volume":"11","author":"Jacobson","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.vaccine.2015.06.031_bib0285","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-0528.2006.01004.x","article-title":"Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue","volume":"113","author":"Cancello","year":"2006","journal-title":"BJOG"},{"issue":"Jan\u2013Mar (2\u20133)","key":"10.1016\/j.vaccine.2015.06.031_bib0290","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0531-5565(01)00213-3","article-title":"Age-associated thymic atrophy is linked to a decline in IL-7 production","volume":"37","author":"Andrew","year":"2002","journal-title":"Exp Gerontol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.06.031_bib0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1464-5491.2011.03544.x","article-title":"Association between age, IL-10, IFNgamma, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes","volume":"29","author":"Kaas","year":"2012","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.031_bib0300","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.2830","article-title":"Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells","volume":"15","author":"Magri","year":"2014","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.06.031_bib0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.2194","article-title":"B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen","volume":"13","author":"Puga","year":"2012","journal-title":"Nat Immunol"},{"issue":"Sep (5)","key":"10.1016\/j.vaccine.2015.06.031_bib0310","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.153.5.1990","article-title":"Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen","volume":"153","author":"Lenschow","year":"1994","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.06.031_bib0315","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/mt.sj.6300129","article-title":"Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines","volume":"15","author":"Song","year":"2007","journal-title":"Mol Ther"},{"issue":"Jun (23)","key":"10.1016\/j.vaccine.2015.06.031_bib0320","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J Biol Chem"},{"issue":"Apr (7)","key":"10.1016\/j.vaccine.2015.06.031_bib0325","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/infdis\/jiq156","article-title":"Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans","volume":"203","author":"Bucasas","year":"2011","journal-title":"J Infect Dis"},{"issue":"Jan (2)","key":"10.1016\/j.vaccine.2015.06.031_bib0330","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2015.06.031_bib0335","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"issue":"Apr (2)","key":"10.1016\/j.vaccine.2015.06.031_bib0340","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","article-title":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses","volume":"157","author":"Tsang","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2015.06.031_bib0345","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2007-1575","article-title":"Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine","volume":"121","author":"Ovsyannikova","year":"2008","journal-title":"Pediatrics"},{"issue":"May (25\u201326)","key":"10.1016\/j.vaccine.2015.06.031_bib0350","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"Sep (5)","key":"10.1016\/j.vaccine.2015.06.031_bib0355","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.4049\/jimmunol.161.5.2223","article-title":"Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes","volume":"161","author":"Dubois","year":"1998","journal-title":"J Immunol"},{"issue":"Sep (3)","key":"10.1016\/j.vaccine.2015.06.031_bib0360","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1189\/jlb.0706481","article-title":"Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation","volume":"82","author":"Mueller","year":"2007","journal-title":"J Leukocyte Biol"},{"issue":"Jun (11)","key":"10.1016\/j.vaccine.2015.06.031_bib0365","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2002-10-3123","article-title":"Macrophage- and dendritic cell\u2014dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF","volume":"101","author":"Craxton","year":"2003","journal-title":"Blood"},{"issue":"Mar (5)","key":"10.1016\/j.vaccine.2015.06.031_bib0370","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.174.5.3015","article-title":"Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma","volume":"174","author":"Ogden","year":"2005","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:15:49Z","timestamp":1691759749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15008208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":37,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15008208"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}